Are graphene and graphene-derived products capable of preventing COVID-19 infection?

Pawan Kumar Raghav; Sujata Mohanty

doi:10.1016/j.mehy.2020.110031

Are graphene and graphene-derived products capable of preventing COVID-19 infection?

Med Hypotheses. 2020 Nov:144:110031. doi: 10.1016/j.mehy.2020.110031. Epub 2020 Jun 24.

Authors

Pawan Kumar Raghav¹, Sujata Mohanty²

Affiliations

¹ Stem Cell Facility, DBT-Centre of Excellence for Stem Cell Research, All India Institute of Medical Sciences, New Delhi 110029, India.
² Stem Cell Facility, DBT-Centre of Excellence for Stem Cell Research, All India Institute of Medical Sciences, New Delhi 110029, India. Electronic address: drmohantysujata@gmail.com.

Abstract

The Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) causes the new coronavirus disease 2019 (COVID-19). This disease is a severe respiratory tract infection that spreading rapidly around the world. In this pandemic situation, the researchers' effort is to understand the targets of the virus, mechanism of their cause, and transmission from animal to human and vice-versa. Therefore, to support COVID-19 research and development, we have proposed approaches based on graphene and graphene-derived nanomaterials against COVID-19.

Keywords: ACE2; COVID-19; Graphene; Graphene oxide; Reduced graphene oxide; SARS-CoV-2.

MeSH terms

Angiotensin-Converting Enzyme 2 / metabolism
Animals
COVID-19 / prevention & control*
Disinfection
Electric Conductivity
Graphite / chemistry
Graphite / therapeutic use*
Humans
Materials Testing
Molecular Dynamics Simulation
Nanomedicine
Nanoparticles
Nanostructures / therapeutic use*
Pandemics
Personal Protective Equipment
Quantum Dots

Substances

Graphite
ACE2 protein, human
Angiotensin-Converting Enzyme 2